The University of Texas Health Science Center, Houston
With
Smart Meter Corporation
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
All patients \>/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
Non-anomalous singletons
Ability to provide informed consent
You may not be if
Patients with Type 1 diabetes
Patients with fetal major congenital abnormalities
Patients identified/referred after 30.6 weeks
Clareo Health | iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
